BackOrion Biotech Opportunities - Warrants (15/04/2025) Overview
Orion Biotech Opportunities Corp - Warrants (15/04/2025)

Orion Biotech Opportunities - Warrants (15/04/2025) Return on Equity

Orion Biotech Opportunities - Warrants (15/04/2025) (ORIAW) has a ROE of 2515104.48%, above the sector sector average of -4.47%.

Get informed when a big investor buys or sells

+ Follow

ROE

2515104.48%

Return on Equity

2515104.48%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

Average ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Orion Biotech Opportunities - Warrants (15/04/2025) (ORIAW) FAQ

Orion Biotech Opportunities - Warrants (15/04/2025) (ORIAW) currently reports a ROE of 2515104.48%. That is above the sector sector average of -4.47%. Use the charts on this page to explore Orion Biotech Opportunities - Warrants (15/04/2025)'s ROE history and peer comparisons.

Orion Biotech Opportunities - Warrants (15/04/2025)'s ROE of 2515104.48% is higher than the its sector sector average of -4.47%. That is roughly 56287131.1% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Orion Biotech Opportunities - Warrants (15/04/2025)'s current 2515104.48% should be judged against industry norms (sector average: -4.47%) and against ORIAW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 2515104.48%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -4.47%. From there, open related valuation or income-statement pages for Orion Biotech Opportunities - Warrants (15/04/2025), and consider following ORIAW for alerts when major investors trade the stock.